Abstract:OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM).DESIGN: Animal-model study.MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05.RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing.CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification. OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM). DESIGN: Animal-model study. MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05. RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing. CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification.

Effects of vitrification on the development potential and transcriptome of human oocyte matured in vitro

Clinical application of vitrification freezing of oocytes

The Effect of Antioxidant Agent During in Vitro Maturation (IVM) of Murine Oocytes on Survival, Fertilization and Early Embryonic Development Following Vitrification

Effects of vitrification on microfilaments′distribution and development potentiality of human in vitro matured oocytes

Effects of Oocyte Vitrification on Gene Expression in the Liver and Kidney Tissues of Adult Offspring

Vitrification of in Vitro-Matured Oocytes: Effects of Meiotic Spindle Morphology on Clinical Outcome

The clinical outcome of human oocytes vitrification in infertility couples

Effects of Vitrification on the Development of Mouse GV-oocytes

Effects of Oocyte Vitrification on Epigenetic Status in Early Bovine Embryos

Effects of meiotic stage-specific oocyte vitrification on mouse oocyte quality and developmental competence

The adverse effects of vitrification on mouse embryo development and metabolic phenotype in offspring

Impacts of vitrification on the transcriptome of human ovarian tissue in patients with gynecological cancer

Oocyte Vitrification Temporarily Turns on Oxidation-Reduction Process Genes in Mouse Preimplantation Embryos

[In Vitro Maturation--n Vitro Fertilization--embryo Transfer--frozen-thawed of Human Oocytes].

Effect of Oocyte Vitrification on DNA Damage in Metaphase II Oocytes and the Resulting Preimplantation Embryos

[Effects of Cryopreservation Time and Thawing Method of Human Oocyte Vitrification on the Outcome of Assisted Reproduction].

Effects of Oocyte Vitrification on Histone Modifications

Research on the In Vitro Maturation and Vitrification of Oocytes from Human Luteal Phase

Effect of Vitrification in OPS on in vitro Maturated Ovine Oocyte's Developmental Potential

RNA-Seq Transcriptome Profiling of Mouse Oocytes after in Vitro Maturation And/or Vitrification

Assessment of the Effect of Different Vitrification Solutions on Human Ovarian Tissue after Short-Term Xenotransplantation Onto the Chick Embryo Chorioallantoic Membrane